Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Khosro Medisa Teb (KMT Group) is a prominent Iranian healthcare conglomerate established in 1990, specializing in the procurement, distribution, and manufacturing of medical devices, pharmaceuticals, and laboratory equipment. The group serves as a critical partner for international healthcare brands, facilitating market entry and providing comprehensive technical support across Iran. KMT operates through a network of specialized subsidiaries focusing on diverse therapeutic areas including ophthalmology, diabetes management, cardiology, and aesthetics. With a robust supply chain infrastructure and local manufacturing capabilities, the company plays a significant role in the Iranian healthcare ecosystem by ensuring the availability of advanced medical technologies and essential medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Khosro Medisa Teb.